سعر انبليت 250مكجم فيال 2026

Nplate (romiplostim) 250 mcg powder for solution for injection, vial (Amgen / Multipharma Egypt listing).

• Treatment of thrombocytopenia in patients with immune thrombocytopenia (ITP) who have had insufficient response to corticosteroids, immunoglobulins, or splenectomy (and other labeled ITP populations per US Nplate label — confirm Egyptian licensed indications).Population: Adults (and pediatric as labeled)DailyMed / FDA

• Common: headache, arthralgia, dizziness, insomnia, myalgia, pain in extremity, abdominal pain, shoulder pain, dyspepsia, paresthesia.International label, same formulation · DailyMed / FDA

• In patients with MDS, Nplate increases blast-cell counts and risk of progression to AML. Thrombotic/thromboembolic complications may occur; do not use to normalize platelets. Monitor CBCs including platelets. Formation of neutralizing antibodies may cause loss of response or worsen thrombocytopenia after discontinuation.International label, same formulation · DailyMed / FDA

• Based on animal data, may cause fetal harm; advise of potential risk (US label).International label, same formulation · DailyMed / FDA

• Romiplostim: Binds and activates the TPO receptor (c-Mpl), increasing platelet production.